Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec
Public ClinicalTrials.gov record NCT02014441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec in Subjects With Unresected, Stage IIIB to IVM1c Melanoma
Study identification
- NCT ID
- NCT02014441
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- Talimogene laherparepvec Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 6, 2014
- Primary completion
- Jan 24, 2016
- Completion
- Apr 18, 2018
- Last update posted
- Nov 19, 2019
2014 – 2018
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tampa | Florida | 33612 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Louisville | Kentucky | 40202 | — |
| Research Site | Fridley | Minnesota | 55432 | — |
| Research Site | Minneapolis | Minnesota | 55407 | — |
| Research Site | New Brunswick | New Jersey | 08903 | — |
| Research Site | Albuquerque | New Mexico | 87106 | — |
| Research Site | Winston-Salem | North Carolina | 27157 | — |
| Research Site | Germantown | Tennessee | 38138 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02014441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02014441 live on ClinicalTrials.gov.